Clinical Trials Browser

Terminated × Hematologic Neoplasms × Daunorubicin × Clear all

NCT03135028 2020-03-06

Japanese AML

Phase 1 Terminated

9 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Hematologic Neoplasms